Table 3.
Reference | Intention to take AD-preventive medicines | Experience of taking Gingko biloba or similar medicines | AD-preventive lifestyle | |
---|---|---|---|---|
OR (95% CI) | OR (95% CI) | B (95% CI) | ||
Socio-demographic factors | ||||
Female | Male | 9.08 (0.65-127.78) | 0.35 (0.14-0.83) | 1.73 (0.14-3.32) |
Age in 50-54 | 45-49 | 0.16 (0.01-4.83) | 1.64 (0.52-5.13) | -0.81 (-3.00-1.38) |
Age in 55-59 | 45-49 | 0.41 (0.01-24.12) | 0.51 (0.15-1.71) | -3.06 (-5.38 - -0.75) |
Age in 60-64 | 45-49 | 0.78 (0.01-46.85) | 0.90 (0.26-3.14) | -1.13 (-3.51-1.24) |
Residence: Others | Metropolitan | 2.14 (0.20-23.16) | 0.75 (0.33-1.71) | 0.85 (-0.72-2.42) |
Education: ≥university | <high school | 6.65 (0.36-121.82) | 0.61 (0.24-1.59) | 1.05 (-0.76-2.87) |
Unmarried | Married | 0.02 (0.00-2.02) | 1.23 (0.22-6.73) | -3.96 (-7.15 - -0.76) |
Monthly income*: ≥3200 USD | < 3200 USD | 1.58 (0.15-16.88) | 2.07 (0.77-5.55) | 0.70 (-1.12-2.51) |
Non-demographic factors | ||||
Perceived susceptibility | +1 score | 1.20 (0.83-1.72) | 1.03 (0.90-1.17) | -0.35 (-0.59 - -0.11) |
Perceived severity | +1 score | 1.02 (0.70-1.49) | 1.00 (0.86-1.17) | -0.16 (-0.45-0.13) |
Perceived benefits | +1 score | 1.06 (0.61-1.84) | 1.07 (0.89-1.27) | -0.02 (-0.34-0.31) |
Perceived barriers | +1 score | 1.07 (0.82-1.39) | 1.01 (0.94-1.08) | 0.08 (-0.05-0.21) |
Self-efficacy | +1 score | 1.39 (1.03-1.87) | 1.07 (0.98-1.18) | 0.18 (0.00-0.36) |
Cue to action | +1 score | 1.21 (0.73-2.02) | 1.22 (1.07-1.40) | 0.25 (0.02-0.48) |
Knowledge of dementia | +1 score | 3.42 (1.13-10.39) | 1.06 (0.78-1.44) | 0.13 (-0.44-0.70) |
Income level was converted from Korean Won (KRW) to USD with the 2020 average currency rate of 0.0008 USD. The median household income for 4-person families were 3799.3 USD in 2020.[26]
AD = Alzheimer’s disease, CI = confidence interval, OR = odds ratio, USD = US Dollar.
OR was derived from a multiple regression analysis; B was derived from a generalized linear regression.